Jeff Garro
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
37
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACCD Accolade | Maintains: Overweight | $10 → $8 | $3.20 | +150.00% | 6 | Oct 9, 2024 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $8 → $7 | $7.70 | -9.09% | 1 | Aug 8, 2024 | |
| EVH Evolent Health | Reiterates: Overweight | $42 | $23.46 | +79.03% | 3 | Jul 30, 2024 | |
| PHR Phreesia | Reiterates: Overweight | $28 | $18.47 | +51.60% | 8 | May 31, 2024 | |
| CERT Certara | Reiterates: Overweight | $20 | $10.25 | +95.12% | 4 | Oct 11, 2023 | |
| TDOC Teladoc Health | Reiterates: Equal-Weight | $28 | $9.21 | +204.02% | 2 | Jul 26, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $18 | $14.26 | +26.23% | 1 | Apr 12, 2023 | |
| PRVA Privia Health Group | Initiates: Overweight | $33 | $18.99 | +73.78% | 1 | Apr 12, 2023 | |
| OPRX OptimizeRx | Maintains: Neutral | $29 → $16 | $5.15 | +210.68% | 2 | Aug 10, 2022 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $15 → $20 | $12.95 | +54.44% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.93 | -34.23% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $2.04 | +47.06% | 3 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $231 → $255 | $209.16 | +21.92% | 1 | Apr 29, 2022 |
Accolade
Oct 9, 2024
Maintains: Overweight
Price Target: $10 → $8
Current: $3.20
Upside: +150.00%
Health Catalyst
Aug 8, 2024
Maintains: Equal-Weight
Price Target: $8 → $7
Current: $7.70
Upside: -9.09%
Evolent Health
Jul 30, 2024
Reiterates: Overweight
Price Target: $42
Current: $23.46
Upside: +79.03%
Phreesia
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $18.47
Upside: +51.60%
Certara
Oct 11, 2023
Reiterates: Overweight
Price Target: $20
Current: $10.25
Upside: +95.12%
Teladoc Health
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $9.21
Upside: +204.02%
R1 RCM
Apr 12, 2023
Initiates: Overweight
Price Target: $18
Current: $14.26
Upside: +26.23%
Privia Health Group
Apr 12, 2023
Initiates: Overweight
Price Target: $33
Current: $18.99
Upside: +73.78%
OptimizeRx
Aug 10, 2022
Maintains: Neutral
Price Target: $29 → $16
Current: $5.15
Upside: +210.68%
Alignment Healthcare
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $12.95
Upside: +54.44%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.93
Upside: -34.23%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $2.04
Upside: +47.06%
Apr 29, 2022
Upgrades: Overweight
Price Target: $231 → $255
Current: $209.16
Upside: +21.92%